Your browser doesn't support javascript.
loading
The protective effect of dietary folate intake on gastric cancer is modified by alcohol consumption: A pooled analysis of the StoP Consortium.
Gonzalez-Palacios, Sandra; Compañ-Gabucio, Laura-María; Torres-Collado, Laura; Oncina-Canovas, Alejandro; García-de-la-Hera, Manuela; Collatuzzo, Giulia; Negri, Eva; Pelucchi, Claudio; Rota, Matteo; López-Carrillo, Lizbeth; Lunet, Nuno; Morais, Samantha; Ward, Mary H; Martin, Vicente; Lozano-Lorca, Macarena; Malekzadeh, Reza; Pakseresht, Mohammadreza; Hernández-Ramírez, Raúl Ulises; Bonzi, Rossella; Patel, Linia; López-Cervantes, Malaquias; Rabkin, Charles S; Tsugane, Shoichiro; Hidaka, Akihisa; Trichopoulou, Antonia; Karakatsani, Anna; Camargo, M Constanza; Curado, Maria Paula; Zhang, Zuo-Feng; La Vecchia, Carlo; Boffetta, Paolo; Vioque, Jesús.
Afiliación
  • Gonzalez-Palacios S; Epidemiología de la Nutrición, Universidad Miguel Hernández (UMH), Alicante, Spain.
  • Compañ-Gabucio LM; Nutritional Epidemiology Research Group, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
  • Torres-Collado L; Group 6, Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Oncina-Canovas A; Epidemiología de la Nutrición, Universidad Miguel Hernández (UMH), Alicante, Spain.
  • García-de-la-Hera M; Nutritional Epidemiology Research Group, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
  • Collatuzzo G; Group 6, Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Negri E; Epidemiología de la Nutrición, Universidad Miguel Hernández (UMH), Alicante, Spain.
  • Pelucchi C; Nutritional Epidemiology Research Group, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
  • Rota M; Group 6, Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • López-Carrillo L; Epidemiología de la Nutrición, Universidad Miguel Hernández (UMH), Alicante, Spain.
  • Lunet N; Nutritional Epidemiology Research Group, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
  • Morais S; Group 6, Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Ward MH; Epidemiología de la Nutrición, Universidad Miguel Hernández (UMH), Alicante, Spain.
  • Martin V; Nutritional Epidemiology Research Group, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
  • Lozano-Lorca M; Group 6, Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Malekzadeh R; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Pakseresht M; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Hernández-Ramírez RU; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Bonzi R; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Patel L; Population Health Research Center, Mexico National Institute of Public Health, Morelos, Mexico.
  • López-Cervantes M; Cancer Epidemiology, EPIUnit - Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
  • Rabkin CS; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
  • Tsugane S; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal.
  • Hidaka A; Cancer Epidemiology, EPIUnit - Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
  • Trichopoulou A; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
  • Karakatsani A; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal.
  • Camargo MC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Curado MP; Nutritional Epidemiology Research Group, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
  • Zhang ZF; Group of Investigation in Interactions Gene-Environment and Health (GIIGAS), Institute of Biomedicine (IBIOMED), Universidad de León, León, Spain.
  • La Vecchia C; Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, Granada, Spain.
  • Boffetta P; Instituto de Investigación Biosanitaria ibs, GRANADA, Granada, Spain.
  • Vioque J; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Int J Cancer ; 2024 May 16.
Article en En | MEDLINE | ID: mdl-38757245
ABSTRACT
Dietary folate intake has been identified as a potentially modifiable factor of gastric cancer (GC) risk, although the evidence is still inconsistent. We evaluate the association between dietary folate intake and the risk of GC as well as the potential modification effect of alcohol consumption. We pooled data for 2829 histologically confirmed GC cases and 8141 controls from 11 case-control studies from the international Stomach Cancer Pooling Consortium. Dietary folate intake was estimated using food frequency questionnaires. We used linear mixed models with random intercepts for each study to calculate adjusted odds ratios (OR) and 95% confidence interval (CI). Higher folate intake was associated with a lower risk of GC, although this association was not observed among participants who consumed >2.0 alcoholic drinks/day. The OR for the highest quartile of folate intake, compared with the lowest quartile, was 0.78 (95% CI, 0.67-0.90, P-trend = 0.0002). The OR per each quartile increment was 0.92 (95% CI, 0.87-0.96) and, per every 100 µg/day of folate intake, was 0.89 (95% CI, 0.84-0.95). There was a significant interaction between folate intake and alcohol consumption (P-interaction = 0.02). The lower risk of GC associated with higher folate intake was not observed in participants who consumed >2.0 drinks per day, ORQ4v Q1 = 1.15 (95% CI, 0.85-1.56), and the OR100 µg/day = 1.02 (95% CI, 0.92-1.15). Our study supports a beneficial effect of folate intake on GC risk, although the consumption of >2.0 alcoholic drinks/day counteracts this beneficial effect.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Cancer Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Cancer Año: 2024 Tipo del documento: Article País de afiliación: España